Finance Watch: Biopharma Firms Get Ahead Of Q3 Updates With Restructuring Reveals
Infinity Files For Bankruptcy, Mallinckrodt’s Approved
Restructuring Edition: Biogen and Sana add to their layoff totals. Exscientia announced R&D program cuts while Syros, PTC, AM-Pharma, Societal CDMO, Nighthawk and Kinnate revealed layoffs to conserve cash. Also, Impel is exploring strategic options and Applied Molecular Transport will disappear in a merger with Cyclo.
